NextCure, Inc. (NXTC) Q4 2024 Annual Earnings
NXTC·Reported March 6, 2025·Before market open
Diluted EPS came in at $-4.92, missed the $-4.08 consensus by $0.84.
Diluted EPS
$-4.92missed by $0.84
Consensus: $-4.08
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about NextCure, Inc.'s Q4 2024 earnings report.
NextCure, Inc. (NXTC) reported Q4 2024 earnings on March 6, 2025 before market open.
NextCure, Inc. reported diluted EPS of $-4.92 for Q4 2024.
EPS missed the consensus estimate of $-4.08 by $0.84.
You can read the 10-K periodic report (0001558370-25-002402) directly on SEC EDGAR. The filing index links above go to sec.gov.